Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues

Magnetic Resonance Imaging

Volumn 26, Issue 8, 2008, Pages 1071-1080

  Noworolski, Susan Moyher ^a   Vigneron, Daniel B ^a   Chen, Albert P ^a   Kurhanewicz, John ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Contrast; DCE MRI; Gadolinium; Glands; MR diffusion; Prostate cancer

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; HUMAN; HUMAN TISSUE; HYPOTHESIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PANCREAS DUCT; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE HYPERTROPHY; REGRESSION ANALYSIS;

AGED; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 51649097613     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2008.01.033     Document Type: Article

References (44)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 57 1 (2007) 43-66
2. Gleason D. Histologic grading of prostatic carcinoma. In: Bostwick D. (Ed). Pathology of the prostate (1990), Churchill Livingstone, New York
3. Fuchs M., Brawer M., Rennels M., and Nagle R. The relationship of basement membrane to histologic grade of human prostatic carcinoma. Mod Pathol 2 (1989) 105-111
4. Noworolski S.M., Henry R.G., Vigneron D.B., and Kurhanewicz J. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med 53 2 (2005) 249-255
5. Engelbrecht M.R., Huisman H.J., Laheij R.J., Jager G.J., van Leenders G.J., Hulsbergen-Van De Kaa C.A., et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229 (2003) 248-254
6. Rouviere O., Raudrant A., Ecochard R., Colin-Pangaud C., Pasquiou C., Bouvier R., et al. Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging. Eur Radiol 13 (2003) 931-942
7. Padhani A.R., Gapinski C.J., Macvicar D.A., Parker G.J., Suckling J., Revell P.B., et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55 2 (2000) 99-109
8. Futterer J.J., Scheenen T.W., Huisman H.J., Klomp D.W., van Dorsten F.A., Hulsbergen-van de Kaa C.A., et al. Initial experience of 3 Tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate. Invest Radiol 39 11 (2004) 671-680
9. Ito H., Kamoi K., Yokoyama K., Yamada K., and Nishimura T. Visualization of prostate cancer using dynamic contrast-enhanced MRI: comparison with transrectal power Doppler ultrasound. Br J Radiol 76 909 (2003) 617-624
10. Preziosi P., Orlacchio A., Di Giambattista G., Di Renzi P., Bortolotti L., Fabiano A., et al. Enhancement patterns of prostate cancer in dynamic MRI. Eur Radiol 13 5 (2003) 925-930
11. 1-weighted MR imaging-initial experience. Radiology 233 3 (2004) 709-715
12. Kozlowski P., Chang S.D., Jones E.C., Berean K.W., Chen H., and Goldenberg S.L. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis-correlation with biopsy and histopathology. J Magn Reson Imaging 24 1 (2006) 108-113
13. Liney G.P., Turnbull L.W., and Knowles A.J. In vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate gland. NMR Biomed 12 (1999) 39-44
14. Barentsz J.O., Engelbrecht M., Jager G.J., Witjes J.A., de LaRosette J., van Der Sanden B.P., et al. Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer. J Magn Reson Imaging 10 3 (1999) 295-304
15. Jager G.J., Ruijter E.T., van de Kaa C.A., de la Rosette J.J., Oosterhof G.O., Thornbury J.R., et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol 166 4 (1996) 845-852
16. Jager G.J., Ruijter E.T., van de Kaa C.A., de la Rosette J.J., Oosterhof G.O., Thornbury J.R., et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 203 3 (1997) 645-652
17. Turnbull L.W., Buckley D.L., Turnbull L.S., Liney G.P., and Knowles A.J. Differentiation of prostatic carcinoma and benign prostatic hyperplasia: correlation between dynamic Gd-DTPA-enhanced MR imaging and histopathology. J Magn Reson Imaging 9 (1999) 311-316
18. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging 16 (2002) 196-200
19. Sato C., Naganawa S., Nakamura T., Kumada H., Miura S., Takizawa O., et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 21 (2005) 258-262
20. Hosseinzadeh K., and Schwarz S.D. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 20 (2004) 654-661
21. Vigneron D., Xu D., Chen A., Swanson M., and Kurhanewicz J. Diffusion tensor imaging of the prostate using single-shot fast spin echo. Proc Intl Soc Magn Reson Med (2002) 457
22. Pickles M.D., Gibbs P., Sreenivas M., and Turnbull L.W. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T. J Magn Reson Imaging 23 2 (2006) 130-134
23. Manenti G., Squillaci E., Di Roma M., Carlani M., Mancino S., and Simonetti G. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging. Radiol Med (Torino) 111 8 (2006) 1124-1133
24. Desouza N.M., Reinsberg S.A., Scurr E.D., Brewster J.M., and Payne G.S. Magnetic resonance imaging in prostate cancer: value of apparent diffusion coefficients for identifying malignant nodules. Br J Radiol 80 950 (2007) 90-95
25. Tofts P.S., and Kermode A.G. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 17 2 (1991) 357-367
26. Tofts P.S. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 7 1 (1997) 91-101
27. Tofts P.S., Brix G., Buckley D.L., Evelhoch J.L., Henderson E., Knopp M.V., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10 3 (1999) 223-232
28. Norris D.G. The effects of microscopic tissue parameters on the diffusion weighted magnetic resonance imaging experiment. NMR Biomed 14 (2001) 77-93
29. Mulkern R.V., Barnes A.S., Haker S.J., Hung Y.P., Rybicki F.J., Maier S.E., et al. Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Magn Reson Imaging 24 5 (2006) 563-568
30. McNeal J., and Bostwick D. Anatomy of the prostate: implications for disease. In: Bostwick D, editor. Pathology of the prostate. Volume 15, Contemporary Issues in Surgical Pathology (1990), Churchill Livingstone, New York
31. Grossfeld G., and Coakley F. Benign prostatic hyperplasia: clinical overview and value of diagnostic imaging. In: Hricak H., and Carroll P. (Eds). The prostate gland: a clinically relevant approach to imaging. Volume 38, The Radiologic Clinics of North America (2000), WB Saunders Company, Philadelphia
32. Kurhanewicz J., Vigneron D.B., Nelson S.J., Hricak H., MacDonald J.M., Konety B., et al. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology 45 (1995) 459-466
33. Kurhanewicz J., Swanson M., Nelson S.J., and Vigneron D. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 16 (2002) 451-463
34. Schricker A.A., Pauly J.M., Kurhanewicz J., Swanson M.G., and Vigneron D.B. Dualband spectral-spatial RF pulses for prostate MR spectroscopic imaging. Magn Reson Med 46 (2001) 1079-1087
35. Alsop D.C. Phase insensitive preparation of single-shot RARE: application to diffusion imaging in humans. Magn Reson Med 38 4 (1997) 527-533
36. Xu D., Henry R.G., Mukherjee P., Carvajal L., Miller S.P., Barkovich A.J., et al. Single-shot fast spin-echo diffusion tensor imaging of the brain and spine with head and phased array coils at 1.5 T and 3.0 T. Magn Reson Imaging 22 6 (2004) 751-759
37. Noworolski S.M., Fischbein N.J., Kaplan M.J., Lu Y., Nelson S.J., Carvajal L., et al. Challenges in dynamic contrast-enhanced MR imaging of cervical lymph nodes to detect metastatic disease. J Magn Reson Imaging. 17 (2003) 455-462
38. Noworolski SM. High spatial resolution magnetic resonance imaging and spectroscopy using surface coils [Ph.D.]. San Francisco and Berkeley: The University of California at San Francisco and the University of California at Berkeley; 1999. p. 326.
39. Nelson S., and Brown T. A new method for automatic quantification of 1-D spectra with low signal to noise ratio. J Magn Reson Imaging 84 (1987) 95-109
40. Nelson S.J. Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med 46 2 (2001) 228-239
41. Lyng H., Haraldseth O., and Rofsttad E.K. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 43 (2000) 828-836
42. Bostwick D.G., and Srigley J.R. Premalignant lesions. In: Bostwick D. (Ed). Pathology of the Prostate (1990), Churchill Livingstone, New York
43. Hricak H. The prostate gland. In: Hricak H., and Carrington B. (Eds). MRI of the pelvis (1991), Martin Dunitz, London 249-311
44. Kjaer L., Thomsen C., Iversen P., and Henriksen O. In vivo estimation of relaxation processes in benign hyperplasia and carcinoma of the prostate gland by magnetic resonance imaging. Magn Reson Imaging 5 1 (1987) 23-30